COVID Treatments

RotaChrom Partnership with Cyclolab – Remdesivir Purification

RotaChrom-Partnership-with-Cyclolab---Remdesivir-Purification

Gyula Kangiszer, President, RotChrom Technologies North America, developers of the first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, discusses the partnership with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab”) aimed at developing a more efficient and cost-effective process to purify Remdesivir, a direct-acting antiviral agent approved in countries around the world to treat patients with severe cases of COVID-19.Bio

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on COVID. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in COVID and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about COVID?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Gyula Kangiszer, President RotaChrom Technologies North America. Gyula is a seasoned strategy and innovation consultant with over 25 years of international experience working for Deloitte, Accenture, Microsoft and EY. He advised leading corporations on a wide range of topics from market strategy through purposeful transformation to operations improvement. Gyula started his career by co-founding and successfully growing a software development company. As the leader of RotaChrom’s North American subsidiary, Gyula is responsible for scaling the operations to stay ahead of the increasing market needs. He also provides strategic advice to customers not only on how to leverage CPC technology, but also how to build their business for long term growth.

Last updated: March 16, 2021

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.